Skip to content
Deciphera Pharmaceuticals Inc icon

Deciphera Pharmaceuticals Inc

DCPHStocksBiotechnologyUnited StatesNasdaqUSD

Price

$25.61

Today

+0.0%

YTD

+0.2%

About

Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on developing drugs targeted at treating serious and rare forms of cancer. Its solutions serve medical communities across the world. It operates in the biotechnology industry, providing treatments that directly inhibit tumour kinases, a type of enzyme cancer cells need for survival. The company uses its switch-control kinase inhibitor platform to develop a portfolio of medicines, including two clinical-stage drug candidates and its approved drug, QINLOCK. Monitor the DCPH share price by adding it to your eToro watchlist.

Price chart
Closing price history for DCPH (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-11.58
P/S (TTM)12.79
P/B (TTM)6.65
Market cap$2.21B
Cap tierMid-cap
Industry avg P/E-5.31

Profitability

Gross margin93.26%
EBIT margin-118.09%
Net margin-100.19%
ROE-50.37%
ROA-39.26%

Earnings & Revenue

Revenue (TTM)$174.91M
Revenue growth (1Y)+26.5%
EPS (TTM)-$2.21
Free cash flow$-152.39M
Total debt$25.02M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.12
Employees355
Next earnings8 Aug '24
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Deciphera Pharmaceuticals Inc (DCPH) | Dirk Kuyken